AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27630085 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma IL-8
Number of subjects: 200
Study 27630085 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma IL-10
Number of subjects: 200
Study 24103043 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental CPAP (4‐10 cmH2O)
Number of subjects: 37
Study 24159691 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopy before intrauterine insemination (IUI)
Number of subjects: 110
Study 24159691 — intervention group
Group type: COMPARATOR
Intervention: Ovulation induction by clomiphene citrate and hCG followed by IUI (Control group)
Number of subjects: 110
Study 18410204 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing
Number of subjects: 69
Study 18410204 — intervention group
Group type: COMPARATOR
Intervention: Control writing
Number of subjects: 69
Study 16163912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin (Group 2)
Number of subjects: 60
Study 16163912 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin (Group 3)
Number of subjects: 60
Study 16163912 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group 1)
Number of subjects: 60
Study 12226606 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser structured base bracket (Discovery, Dentaurum)
Number of subjects: 120
Study 12226606 — intervention group
Group type: COMPARATOR
Intervention: Simple foil mesh bracket (Minitrim, Dentaurum)
Number of subjects: 120
Study 10583311 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg 17beta-oestradiol daily
Number of subjects: 25
Study 10583311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8582471 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexibuprofen 400 mg tablet formulation
Number of subjects: 0
Study 8582471 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexibuprofen 200, 400, and 600 mg
Number of subjects: 0
Study 8582471 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen racemate 400, 800, and 1200 mg
Number of subjects: 0
Study 2118408 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA-enriched TPN (0.56 g BCAA kg‐1 body-weight, 50.2% BCAA)
Number of subjects: 101
Study 2118408 — intervention group
Group type: COMPARATOR
Intervention: Standard TPN (0.18 g BCAA kg‐1 body-weight, 15.6% BCAA)
Number of subjects: 101
Study 2118408 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA-enriched TPN
Number of subjects: 101
Study 2118408 — intervention group
Group type: COMPARATOR
Intervention: Standard TPN
Number of subjects: 101
Study 336379 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and timolol
Number of subjects: 24
Study 336379 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and amiloride
Number of subjects: 24
Study 336379 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide and placebo
Number of subjects: 24
Study 336379 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and timolol and amiloride
Number of subjects: 24
Study 29028762 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of morphine and midazolam
Number of subjects: 60
Study 29028762 — intervention group
Group type: COMPARATOR
Intervention: Intermittent dosing only
Number of subjects: 60
Study 27567239 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis plus mechanical thrombectomy (IVTMT group)
Number of subjects: 414
Study 27567239 — intervention group
Group type: COMPARATOR
Intervention: Intravenous thrombolysis alone (IVT group)
Number of subjects: 414
Study 27567239 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IVT and IVTMT)
Number of subjects: 414
Study 27567239 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy related adverse events
Number of subjects: 414
Study 25338640 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebent reconstruction plates molded to MRP mandibular models
Number of subjects: 28
Study 25338640 — intervention group
Group type: COMPARATOR
Intervention: Conventional reconstruction methods
Number of subjects: 28
Study 22370531 — intervention group
Group type: EXPERIMENTAL
Intervention: CIC‐HFA 74 micrograms
Number of subjects: 0
Study 22370531 — intervention group
Group type: EXPERIMENTAL
Intervention: CIC‐HFA 148 micrograms
Number of subjects: 0
Study 22370531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20864406 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of imatinib treatment
Number of subjects: 434
Study 20864406 — intervention group
Group type: COMPARATOR
Intervention: Interruption of imatinib treatment
Number of subjects: 434
Study 18421069 — intervention group
Group type: EXPERIMENTAL
Intervention: Male-to-female transsexuals (group 3)
Number of subjects: 55
Study 18421069 — intervention group
Group type: COMPARATOR
Intervention: Males (group 1)
Number of subjects: 55
Study 18421069 — intervention group
Group type: COMPARATOR
Intervention: Females (group 2)
Number of subjects: 55
Study 18421069 — intervention group
Group type: EXPERIMENTAL
Intervention: Female-to-male transsexuals (group 4)
Number of subjects: 55
Study 18421069 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin levels
Number of subjects: 55
Study 15812075 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance vinorelbine (25 mg/m²/week for 6 months)
Number of subjects: 181
Study 15812075 — intervention group
Group type: COMPARATOR
Intervention: Observation (no further treatment)
Number of subjects: 181
Study 15812075 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance vinorelbine
Number of subjects: 181
Study 12540401 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exposure (physical stress)
Number of subjects: 12
Study 12540401 — intervention group
Group type: EXPERIMENTAL
Intervention: Arithmetic calculations (mental stress)
Number of subjects: 12
Study 12540401 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark exposure (emotional stress)
Number of subjects: 12
Study 12540401 — intervention group
Group type: EXPERIMENTAL
Intervention: Diurnal variations in nicotinamide metabolites
Number of subjects: 12
Study 10759821 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% 5‐FU in a PC vehicle (cream A)
Number of subjects: 13
Study 10759821 — intervention group
Group type: COMPARATOR
Intervention: 5% 5‐FU in a petrolatum base (cream B)
Number of subjects: 13
Study 9322481 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorzoxazone (500 mg orally on the morning of surgery)
Number of subjects: 30
Study 9322481 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chlorzoxazone administration)
Number of subjects: 30
Study 8445418 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (400 mg/m2)
Number of subjects: 254
Study 8445418 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-abdominal radiotherapy (24 Gy)
Number of subjects: 254
Study 3781021 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bromocriptine (1.25 to 2.5 mg) at bedtime for the first 18 days of the cycle (Group A)
Number of subjects: 43
Study 3781021 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (similar to Group A) with clomiphene citrate (Group C)
Number of subjects: 43
Study 3781021 — intervention group
Group type: COMPARATOR
Intervention: Pyridoxine (100 mg continuously) (Group B)
Number of subjects: 43
Study 30201202 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based psychoeducation program
Number of subjects: 135
Study 30201202 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study 26967831 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 50
Study 26967831 — intervention group
Group type: COMPARATOR
Intervention: intubation
Number of subjects: 50
Study 24789134 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed hands-on training session (Sim group)
Number of subjects: 56
Study 24789134 — intervention group
Group type: COMPARATOR
Intervention: Unstructured hands-on session (control group)
Number of subjects: 56
Study 22624289 — intervention group
Group type: EXPERIMENTAL
Intervention: Active head-tilt condition
Number of subjects: 0
Study 22624289 — intervention group
Group type: COMPARATOR
Intervention: Natural head-tilt condition
Number of subjects: 0
Study 20156908 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg) plus Lapatinib (1,500 mg)
Number of subjects: 1286
Study 20156908 — intervention group
Group type: COMPARATOR
Intervention: Letrozole (2.5 mg) plus Placebo
Number of subjects: 1286
Study 18577934 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg daily
Number of subjects: 0
Study 18577934 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 0
Study 18577934 — intervention group
Group type: EXPERIMENTAL
Intervention: Small dosages of amitriptyline and fluvoxamine with transcranial electrostimulation
Number of subjects: 0
Study 18577934 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antidepressants with transcranial electrostimulation
Number of subjects: 0
Study 15784061 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 200
Study 15784061 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 200
Study 11450419 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage cylindrical screw implants with a synthetic bone substitute
Number of subjects: 0
Study 11450419 — intervention group
Group type: EXPERIMENTAL
Intervention: Hollow screw-type implants
Number of subjects: 0
Study 11450419 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid screw-type implants
Number of subjects: 0
Study 11450419 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage implant osseointegration with synthetic graft material
Number of subjects: 0
Study 9669455 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine-containing toothpaste (4% betaine)
Number of subjects: 13
Study 9669455 — intervention group
Group type: COMPARATOR
Intervention: Regular toothpaste (without betaine)
Number of subjects: 13
Study 8114833 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patches
Number of subjects: 72
Study 8114833 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 72
Study 3043555 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceruletide (0.8 micrograms/kg, intramuscular injections, once weekly for 4 weeks)
Number of subjects: 37
Study 3043555 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intramuscular injections, once weekly for 4 weeks)
Number of subjects: 37
Study 8230622 — intervention group
Group type: EXPERIMENTAL
Intervention: Active antiarrhythmic drug therapy (encainide, flecainide, moricizine)
Number of subjects: 3549
Study 8230622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3549
Study 681543 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose marihuana
Number of subjects: 48
Study 681543 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose marihuana
Number of subjects: 48
Study 681543 — intervention group
Group type: COMPARATOR
Intervention: Coltsfoot
Number of subjects: 48
Study 681543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 31053619 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made acrylic titratable MAD (TALI)
Number of subjects: 198
Study 31053619 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoplastic heat-moulded titratable MAD (ONIRIS)
Number of subjects: 198
Study 31053619 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 198
Study 27923264 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinent Contingent Group (AC)
Number of subjects: 94
Study 27923264 — intervention group
Group type: COMPARATOR
Intervention: Submission Contingent Group (SC)
Number of subjects: 94
Study 25572623 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater frequency of receiving 5A instruction
Number of subjects: 1065
Study 25572623 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of preceptors as excellent role models in tobacco treatment
Number of subjects: 1065
Study 25572623 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater 5A instruction
Number of subjects: 1065
Study 25572623 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation of tobacco treatment
Number of subjects: 1065
Study 23228172 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (1000 mg) plus prednisone (5 mg twice daily)
Number of subjects: 1088
Study 23228172 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 1088
Study 21750078 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty
Number of subjects: 209
Study 21750078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 19574407 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 524
Study 19574407 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Treatment (CBT)
Number of subjects: 524
Study 19574407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 524
Study 19574407 — intervention group
Group type: COMPARATOR
Intervention: Standard Smoking Cessation CBT
Number of subjects: 524
Study 17132719 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose cyclophosphamide (3.3 g/m2)
Number of subjects: 637
Study 17132719 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose cyclophosphamide (1.65 g/m2)
Number of subjects: 637
Study 17132719 — intervention group
Group type: EXPERIMENTAL
Intervention: With maintenance course M1
Number of subjects: 637
Study 17132719 — intervention group
Group type: EXPERIMENTAL
Intervention: Without maintenance course M1
Number of subjects: 637
Study 15529609 — intervention group
Group type: EXPERIMENTAL
Intervention: Diosmectite 3 g b.i.d.
Number of subjects: 50
Study 15529609 — intervention group
Group type: COMPARATOR
Intervention: Loperamide 2 mg b.i.d.
Number of subjects: 50
Study 15529609 — intervention group
Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 50
Study 11167469 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.025 mg x kg(‐1)
Number of subjects: 120
Study 11167469 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg x kg(‐1)
Number of subjects: 120
Study 11167469 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 120
Study 9596231 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke unit treatment
Number of subjects: 220
Study 9596231 — intervention group
Group type: COMPARATOR
Intervention: General wards treatment
Number of subjects: 220
Study 7811050 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil 15 mg/kg
Number of subjects: 89
Study 7811050 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil 20 mg/kg
Number of subjects: 89
Study 3293253 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy combined with indomethacin at a daily dose of 75-100 mg
Number of subjects: 33
Study 3293253 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy alone
Number of subjects: 33
Study 31989965 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening and stretching exercises
Number of subjects: 619
Study 31989965 — intervention group
Group type: COMPARATOR
Intervention: Deep tissue massage
Number of subjects: 619
Study 31989965 — intervention group
Group type: COMPARATOR
Intervention: Combined therapy (massage and exercises)
Number of subjects: 619
Study 31989965 — intervention group
Group type: COMPARATOR
Intervention: Advice to stay active
Number of subjects: 619
Study 29304245 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 0
Study 29304245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27562777 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy snack
Number of subjects: 108
Study 27562777 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit
Number of subjects: 108
Study 27562777 — intervention group
Group type: EXPERIMENTAL
Intervention: Snack-fruit condition
Number of subjects: 108
Study 27562777 — intervention group
Group type: COMPARATOR
Intervention: Fruit-snack condition
Number of subjects: 108
Study 27562777 — intervention group
Group type: COMPARATOR
Intervention: Reward sensitivity
Number of subjects: 108
Study 24866279 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional colporrhaphy and mesh repair surgery
Number of subjects: 164
Study 22331405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (at least four group sessions)
Number of subjects: 198
Study 22331405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (high attendance)
Number of subjects: 198
Study 21112904 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and strength training (twice a week for 20 weeks)
Number of subjects: 16
Study 21112904 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 16
Study 21112904 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and strength training
Number of subjects: 16
Study 19440326 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART (initiated within 14 days of starting acute OI treatment)
Number of subjects: 282
Study 19440326 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART (initiated after acute OI treatment is completed)
Number of subjects: 282
Study 16477653 — intervention group
Group type: EXPERIMENTAL
Intervention: Vt = 5 ml/kg
Number of subjects: 30
Study 16477653 — intervention group
Group type: COMPARATOR
Intervention: Vt = 3 ml/kg
Number of subjects: 30
Study 15023577 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpsychotic relatives of persons with schizophrenia
Number of subjects: 24
Study 15023577 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 24
Study 11800144 — intervention group
Group type: EXPERIMENTAL
Intervention: 30mg acitretin daily
Number of subjects: 29
Study 11800144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 9483596 — intervention group
Group type: EXPERIMENTAL
Intervention: suxamethonium 1.0 mg.kg‐1
Number of subjects: 60
Study 9483596 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg.kg‐1
Number of subjects: 60
Study 7848890 — intervention group
Group type: EXPERIMENTAL
Intervention: IV vinorelbine (30 mg/m2 weekly)
Number of subjects: 54
Study 3184107 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrice daily hydrocortisone replacement
Number of subjects: 7
Study 3184107 — intervention group
Group type: COMPARATOR
Intervention: Twice daily hydrocortisone replacement
Number of subjects: 7
Study 30193001 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (0.8 mg)/vitamin B12 (0.4 mg)/vitamin B6 (40 mg)
Number of subjects: 2049
Study 30193001 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid/vitamin B12
Number of subjects: 2049
Study 30193001 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6
Number of subjects: 2049
Study 30193001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2049
Study 29179765 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer advocates disclosing personal details about their lives
Number of subjects: 5
Study 26387934 — intervention group
Group type: EXPERIMENTAL
Intervention: Oocyte retrieval at 36 hours post-HCG administration (n = 78)
Number of subjects: 156
Study 26387934 — intervention group
Group type: COMPARATOR
Intervention: Oocyte retrieval at 38 hours post-HCG administration (n = 78)
Number of subjects: 156
Study 22849970 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat/low-saturated fat/low-glycaemic index diet (LSAT: 23% fat, 7% saturated fat, GI < 55)
Number of subjects: 20
Study 22849970 — intervention group
Group type: COMPARATOR
Intervention: High-fat/high-saturated fat/high-glycaemic index diet (HSAT: 43% fat, 24% saturated fat, GI > 70)
Number of subjects: 20
Study 21493302 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative nasal packing in patients with mild OSA (RDI <15)
Number of subjects: 49
Study 21493302 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative nasal packing in patients with moderate/severe OSA (RDI ≥15)
Number of subjects: 49
Study 19660597 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarct size estimated by peak serum CK-MB concentration
Number of subjects: 3491
Study 16411990 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 9996
Study 16411990 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate for severe pre-eclampsia
Number of subjects: 9996
Study 15257791 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg loading dose of beta-artemether
Number of subjects: 223
Study 15257791 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg loading dose of beta-artemether
Number of subjects: 223
Study 11567707 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoprevention treatment trials
Number of subjects: 0
Study 11567707 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-reducing mastectomy (RRM)
Number of subjects: 0
Study 11567707 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI breast screening
Number of subjects: 0
Study 9304981 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified one-day bowel cleaning
Number of subjects: 48
Study 9304981 — intervention group
Group type: COMPARATOR
Intervention: Traditional three-day bowel preparation
Number of subjects: 48
Study 8465173 — intervention group
Group type: EXPERIMENTAL
Intervention: Toluene exposure at 2 mg.min-1 for 3 hours
Number of subjects: 8
Study 8465173 — intervention group
Group type: EXPERIMENTAL
Intervention: Toluene exposure at 6 mg.min-1 for 30 minutes
Number of subjects: 8
Study 8465173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol ingestion at 0.08 g.kg-1 during toluene exposure at 2 mg.min-1
Number of subjects: 8
Study 8465173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol ingestion at 0.16 g.kg-1 during toluene exposure at 2 mg.min-1
Number of subjects: 8
Study 8465173 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol ingestion at 0.32 g.kg-1 during toluene exposure at 2 mg.min-1
Number of subjects: 8
Study 3810714 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol administration
Number of subjects: 26
Study 3810714 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 26
Study 31036759 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium oxide (MgO)
Number of subjects: 125